Teligent Stock Forecast, Price & News

Wall Street analysts have given Teligent a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Teligent wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Teligent saw a decrease in short interest during the month of August. As of August 31st, there was short interest totaling 1,470,000 shares, a decrease of 33.5% from the August 15th total of 2,210,000 shares. Based on an average daily volume of 3,250,000 shares, the short-interest ratio is currently 0.5 days. Approximately 1.6% of the company's shares are sold short.
View Teligent's Short Interest.

Teligent is scheduled to release its next quarterly earnings announcement on Thursday, December 30th 2021.
View our earnings forecast for Teligent.

Teligent, Inc. (NASDAQ:TLGT) released its earnings results on Monday, August, 16th. The company reported ($0.14) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.13) by $0.01.
View Teligent's earnings history.

Teligent's stock was trading at $3.25 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TLGT shares have decreased by 88.7% and is now trading at $0.3680.
View which stocks have been most impacted by COVID-19.

Teligent's stock reverse split on the morning of Thursday, May 28th 2020. The 1-10 reverse split was announced on Wednesday, May 27th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, May 27th 2020. An investor that had 100 shares of Teligent stock prior to the reverse split would have 10 shares after the split.

2 employees have rated Teligent CEO Tim Sawyer on Glassdoor.com. Tim Sawyer has an approval rating of 100% among Teligent's employees. This puts Tim Sawyer in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Teligent include Genprex (GNPX), Ardelyx (ARDX), Medicenna Therapeutics (MDNA), SCYNEXIS (SCYX), Vascular Biogenics (VBLT), Lannett (LCI), NeuBase Therapeutics (NBSE), Oasmia Pharmaceutical AB (publ) (OASMY), BioLineRx (BLRX), Lantern Pharma (LTRN), ProMetic Life Sciences (PFSCF), Purple Biotech (PPBT), NuCana (NCNA), Longboard Pharmaceuticals (LBPH) and Orgenesis (ORGS).
View all of TLGT's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Teligent investors own include Novavax (NVAX), ChemoCentryx (CCXI), Voyager Therapeutics (VYGR), AbbVie (ABBV), General Electric (GE), Biocept (BIOC), Lannett (LCI), Pfizer (PFE), Selecta Biosciences (SELB) and VBI Vaccines (VBIV).

Teligent trades on the NASDAQ under the ticker symbol "TLGT."

Teligent's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Silverback Asset Management LLC (3.79%), Nantahala Capital Management LLC (2.61%), Vanguard Group Inc. (0.99%), Geode Capital Management LLC (0.61%), Renaissance Technologies LLC (0.33%) and Citadel Advisors LLC (0.33%). Company insiders that own Teligent stock include R Carter Pate and Sciences Opportunities Fu Life.
View institutional ownership trends for Teligent.

TLGT stock was sold by a variety of institutional investors in the last quarter, including Nantahala Capital Management LLC, Silverback Asset Management LLC, Renaissance Technologies LLC, and Virtu Financial LLC.
View insider buying and selling activity for Teligent or view top insider-selling stocks.

TLGT stock was bought by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Geode Capital Management LLC, Citadel Advisors LLC, Millennium Management LLC, Morgan Stanley, Morgan Stanley, and Northern Trust Corp.
View insider buying and selling activity for Teligent or or view top insider-buying stocks.

Shares of TLGT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TLGT stock can currently be purchased for approximately $0.37.

Teligent has a market capitalization of $34.16 million and generates $45.31 million in revenue each year.

Teligent employs 2,357 workers across the globe.

The official website for Teligent is www.teligent.com.

Teligent is headquartered at 105 LINCOLN AVENUE, BUENA NJ, 08310.

Teligent's mailing address is 105 LINCOLN AVENUE, BUENA NJ, 08310. The company can be reached via phone at (856) 697-1441 or via email at [email protected].